Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).

Kerwin, Edward M

Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). [electronic resource] - COPD Apr 2012 - 90-101 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1541-2563

10.3109/15412555.2012.661492 doi


Administration, Inhalation
Adult
Aged
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Intention to Treat Analysis
Male
Middle Aged
Muscarinic Antagonists--administration & dosage
Pulmonary Disease, Chronic Obstructive--drug therapy
Quality of Life
Spirometry
Surveys and Questionnaires
Treatment Outcome
Tropanes--administration & dosage